Patents Assigned to Merck Patents GmbH
  • Publication number: 20210102122
    Abstract: The invention relates to a liquid-crystalline medium comprising one or more compounds of the formula CC in which the groups occurring have the meanings indicated in Claim 1, and to the use of the liquid-crystalline medium for electro-optical purposes, in particular in liquid-crystal light valves for lighting devices for vehicles, and to liquid-crystal light valves which comprise this medium and lighting devices for vehicles which contain liquid-crystal light valves of this type.
    Type: Application
    Filed: April 24, 2018
    Publication date: April 8, 2021
    Applicant: Merck Patent GmbH
    Inventors: Michael WITTEK, Dagmar KLASS
  • Publication number: 20210101929
    Abstract: The present invention relates to a method for stabilizing protein or peptide comprising formulations, which includes the step of adding selected meglumine salts to protein solutions, especially to solutions of pharmaceutical active proteins. But the present invention also relates to the stabilized composition comprising proteins or peptides and selected meglumine salts. Another objective of the present invention is to provide pharmaceutical compositions comprising antibody molecules stabilized by selected meglumine salts and methods for producing corresponding stabilized pharmaceutical compositions, and kit comprising these compositions.
    Type: Application
    Filed: April 16, 2019
    Publication date: April 8, 2021
    Applicant: MERCK PATENT GMBH
    Inventors: Christoph KORPUS, Raphael Johannes GUEBELI
  • Patent number: 10971689
    Abstract: The present invention relates to compounds of the formula (1) and (2) which are suitable for use in electro¬nic devices, in particular organic electroluminescent devices.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: April 6, 2021
    Assignee: Merck Patent GmbH
    Inventors: Philipp Stoessel, Dominik Joosten, Arne Buesing
  • Publication number: 20210096431
    Abstract: A double layer liquid crystal device comprises a first and a second layer with orthogonal or crossed alignment of the liquid crystal phase of the two layers, in which the first and second layer have first and second alignment aids comprised of a polymerized or polymerizable molecular compound. The layers are aligned by UV photoalignment and vertical self-alignment by the aid of suitable additives.
    Type: Application
    Filed: September 25, 2020
    Publication date: April 1, 2021
    Applicant: Merck Patent GmbH
    Inventors: Joseph SARGENT, Sarabjot KAUR, Simon SIEMIANOWSKI, Izumi SAITO
  • Patent number: 10961457
    Abstract: The present invention relates to liquid-crystalline media comprising a) one or more compounds of the formula ST-1, as defined herein, and b) one or more compounds of the formula ST-2, as defined herein, and c) one or more compounds of the formula RV, as defined herein, and d) one or more compounds selected from formula IA and IB, as defined herein, and to liquid-crystal displays containing these media, especially to displays addressed by an active matrix and in particular to displays of the in-plane switching (IPS) or fringe-field switching (FFS) type.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: March 30, 2021
    Assignee: Merck Patent GmbH
    Inventors: Chang-Jun Yun, Chang-Suk Choi, Yeon-Jeong Han, Heui-Seok Jin, Yong-Kuk Yun
  • Patent number: 10961230
    Abstract: The present invention describes amines with dibenzofuran or dibenzothiophene groups in combination with carbazole, especially for use as triplet matrix materials in organic electroluminescent devices. The invention further relates to a process for preparing the compounds of the invention and to electronic devices comprising these compounds.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: March 30, 2021
    Assignee: Merck Patent GmbH
    Inventors: Amir Hossain Parham, Thomas Eberle, Anja Jatsch, Tobias Grossmann, Jonas Valentin Kroeber, Elvira Montenegro, Dominik Joosten, Caroline Wern
  • Patent number: 10964894
    Abstract: The present invention relates to carbazole derivatives, especially for use in electronic devices. The invention further relates to a process for preparing the compounds of the invention and to electronic devices comprising these.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: March 30, 2021
    Assignee: Merck Patent GmbH
    Inventors: Amir Parham, Aurélie Ludemann, Dominik Joosten, Tobias Grossmann, Jonas Kroeber
  • Publication number: 20210087403
    Abstract: Pigments based on particles which are coated with at least one layer which consists of a mixture of amorphous carbon (a-C) and nanocrystalline graphite (nc-graphite) and use of these pigments in, for example, paints, plastics, industrial coatings, automotive coatings, printing inks and cosmetic formulations.
    Type: Application
    Filed: September 1, 2020
    Publication date: March 25, 2021
    Applicant: MERCK PATENT GMBH
    Inventors: Adeliene SCHMITT, Udo GUMSHEIMER
  • Publication number: 20210085611
    Abstract: A pharmaceutical formulation has (S)-[2-chloro-4-fluoro-5-(7-tnorpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)methanol or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 28, 2018
    Publication date: March 25, 2021
    Applicant: Merck Patent GmbH
    Inventors: Simon GEISSLER, Martina Jeschke, Patrizia Boniforte, Markus Weigandt
  • Patent number: 10954323
    Abstract: The present invention relates to novel fluorine containing polymers, compositions comprising the polymers, the use of the polymers in coatings, especially in water and dirt repellent coatings, and products coated with polymer containing coatings.
    Type: Grant
    Filed: June 14, 2017
    Date of Patent: March 23, 2021
    Assignee: MERCK PATENT GMBH
    Inventors: Haibo Fang, Reiner Friedrich
  • Patent number: 10954403
    Abstract: The present invention relates to an ink composition comprising an organic functional material having a molecular weight of at most 5,000 g/mol and a first organic solvent selected from the group consisting of terpene, terpenoid, and combination of any of these, as well as to the use of the ink composition, an electronic device prepared by using the ink composition and method for preparing/fabricating thereof.
    Type: Grant
    Filed: November 25, 2016
    Date of Patent: March 23, 2021
    Assignee: Merck Patent GmbH
    Inventors: Li Wei Tan, Pawel Miskiewicz, Philip Edward May, Daniel Walker
  • Patent number: 10957860
    Abstract: The application relates to a compound of a formula (I) which is suitable for use as functional material in electronic devices.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: March 23, 2021
    Assignee: Merck Patent GmbH
    Inventors: Teresa Mujica-Fernaud, Elvira Montenegro, Frank Voges, Jonas Valentin Kroeber, Philipp Stoessel
  • Patent number: 10957864
    Abstract: The invention relates to compounds which are suitable for use in electronic devices, and electronic devices, in particular organic electroluminescent devices, containing said compounds.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: March 23, 2021
    Assignee: Merck Patent GmbH
    Inventors: Amir Hossain Parham, Anja Jatsch, Tobias Grossmann, Thomas Eberle, Jonas Valentin Kroeber, Rouven Linge
  • Patent number: 10957859
    Abstract: The present invention relates to heterocyclic compounds and to electronic devices, especially organic electroluminescent devices, comprising these compounds.
    Type: Grant
    Filed: November 3, 2015
    Date of Patent: March 23, 2021
    Assignee: Merck Patent GmbH
    Inventors: Anja Jatsch, Amir Hossain Parham, Thomas Eberle, Tobias Grossmann, Jonas Valentin Kroeber
  • Publication number: 20210077370
    Abstract: The non-therapeutical, cosmetic use of dihydroxyacetone in a cosmetic composition to be applied on skin, scalp, or hair for the protection of skin, scalp, or hair against infrared irradiation as well as the use of a cosmetic composition containing dihydroxyacetone as an agent for controlling tropoelastin expression in living cells of the epidermis and papillary dermis or as an agent for controlling the degradation of extracellular matrix components in living cells of the epidermis and papillary dermis, and dihydroxyacetone as an active ingredient to protect skin, scalp, or hair against damages after infrared irradiation by reacting with the skin, scalp, or hair or by penetrating the skin, scalp, or hair.
    Type: Application
    Filed: September 11, 2020
    Publication date: March 18, 2021
    Applicant: Merck Patent GmbH
    Inventors: Valerie BICARD-BENHAMOU, Lilia HEIDER, Marina LEFORT, Jutta ZUR LAGE
  • Patent number: 10947213
    Abstract: Compounds of Formula 1 and pharmaceutically acceptable compositions thereof are useful as TLR7/8 antagonists.
    Type: Grant
    Filed: April 28, 2020
    Date of Patent: March 16, 2021
    Assignee: Merck Patent GmbH
    Inventors: Brian A. Sherer, Nadia Brugger
  • Patent number: 10947214
    Abstract: The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TLR7/8 antagonists.
    Type: Grant
    Filed: August 7, 2017
    Date of Patent: March 16, 2021
    Assignee: Merck Patent GmbH
    Inventors: Brian A. Sherer, Xiaoling Chen, Esther Cleary, Nadia Brugger
  • Patent number: 10950792
    Abstract: The present invention relates to a formulation containing at least one organic functional material and at least two different organic solvents, a first organic solvent A and a second organic solvent B, wherein the first organic solvent A has a boiling point in the range from 250 to 350° C. and a viscosity of >15 mPas, the second organic solvent B has a boiling point in the range from 200 to 350° C. and a viscosity of ?10 mPas, the solubility of the at least one organic functional material in the second organic solvent B is ?5 g/l, and the boiling point of the first organic solvent A is at least 10° C. higher than the boiling point of the second organic solvent B; as well as to electroluminescent devices prepared by using these formulations.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: March 16, 2021
    Assignee: Merck Patent GmbH
    Inventors: Gaëlle Béalle, Christoph Leonhard, Hsin-Rong Tseng, Manuel Hamburger, Anja Jatsch
  • Patent number: D914835
    Type: Grant
    Filed: February 14, 2019
    Date of Patent: March 30, 2021
    Assignee: Merck Patent GmbH
    Inventors: Laurent Moreau, Thierry Cassou
  • Patent number: D915549
    Type: Grant
    Filed: May 8, 2019
    Date of Patent: April 6, 2021
    Assignee: Merck Patent GmbH
    Inventors: Christian Berducat, Pascal Delahaie